Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bovie Medical Corp (BVX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 153,716
  • Shares Outstanding, K 33,200
  • Annual Sales, $ 38,880 K
  • Annual Income, $ -5,060 K
  • 36-Month Beta -1.04
  • Price/Sales 3.97
  • Price/Cash Flow N/A
  • Price/Book 7.16

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.48 +8.48%
on 08/16/18
5.36 -9.33%
on 07/23/18
-0.24 (-4.71%)
since 07/17/18
3-Month
3.68 +32.07%
on 06/13/18
5.49 -11.48%
on 07/09/18
+0.78 (+19.12%)
since 05/17/18
52-Week
2.20 +120.91%
on 08/22/17
5.49 -11.48%
on 07/09/18
+2.32 (+91.34%)
since 08/17/17

Most Recent Stories

More News
Bovie Medical Corporation to Release Second Quarter of Fiscal Year 2018 Financial Results on August 1, 2018

Bovie Medical (NYSE: BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the Renuvion(TM) Cosmetic Technology...

BVX : 4.86 (+4.97%)
RoundTable Healthcare Partners and Symmetry Surgical Inc. to Acquire Bovie Medical's Electrosurgical Business

RoundTable Healthcare Partners ("RoundTable"), an operating- oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Symmetry Surgical Inc.,...

SSRG : 13.18 (+0.38%)
BVX : 4.86 (+4.97%)
Bovie Medical Corporation Announces Agreement to Sell "Core" Business Segment to Symmetry Surgical, Inc. for Total Cash Consideration of $97 million

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the...

SSRG : 13.18 (+0.38%)
BVX : 4.86 (+4.97%)
Bovie Medical Corporation Announces Preliminary Second Quarter 2018 Revenue Results

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the...

BVX : 4.86 (+4.97%)
Bovie Medical Corporation to Participate in the JMP Securities 2018 Life Science Conference

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the...

BVX : 4.86 (+4.97%)
Bovie Medical Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 14, 2018 / Bovie Medical Corporation (NYSE American: ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 14, 2018 at 4:30 PM Eastern...

BVX : 4.86 (+4.97%)
Bovie Medical Corporation Announces Completion of Enrollment in J-Plasma(R)/Renuvion(TM) Dermal Resurfacing Study

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the...

BVX : 4.86 (+4.97%)
Bovie Medical Corporation Announces Appointment of Diane I. Duncan, M.D., FACS to Medical Advisory Board

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the...

BVX : 4.86 (+4.97%)
Bovie Medical Corporation to Release First Quarter of Fiscal Year 2018 Financial Results on May 14, 2018

Bovie Medical (NYSE: BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, today announced that financial results for the first...

BVX : 4.86 (+4.97%)
Bovie Medical Corporation Announces Launch of Renuvion(TM): A New Brand Dedicated to the Cosmetic Surgery Market

Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product, today announced the launch...

BVX : 4.86 (+4.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade BVX with:

Business Summary

Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devicesand advanced coating technologies.

See More

Key Turning Points

2nd Resistance Point 5.19
1st Resistance Point 5.02
Last Price 4.86
1st Support Level 4.62
2nd Support Level 4.39

See More

52-Week High 5.49
Last Price 4.86
Fibonacci 61.8% 4.23
Fibonacci 50% 3.84
Fibonacci 38.2% 3.46
52-Week Low 2.20

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar